Searchable abstracts of presentations at key conferences in endocrinology

ea0077cc3 | (1) | SFEBES2021

Hypercalcemia caused by Advanced Chronic liver disease without Malignancy: A rare entity

Jadoon Nauman , Khan Muhammad , Zafar Athesham

Background: Hypercalcemia in patients with advanced chronic liver disease (CLD) without hepatic neoplasia is a rarely reported and poorly understood entity. CLD is usually associated with hypocalcaemia because of hypoalbuminemia. Hypercalcemia on the other hand is extremely rare and needs meticulous ruling out of other causes.Case Report: A 55-year-old male who was admitted with jaundice, weight loss and hypercalcaemia. He had a calcium that peaked at 3....

ea0077p69 | Metabolism, Obesity and Diabetes | SFEBES2021

Persistent Lactic Acidosis after resolution of DKA in Young Patients with Poorly Controlled Diabetes Mellitus

Jadoon Nauman , Noor Sajjad , Khan Muhammad

Background: Lactic acidosis is a common finding in critically ill patients. In patients with poorly controlled diabetes for a prolonged period of time, Glycogenic hepatopathy (GH), can cause lactic acidosis which is a rare condition that develops due to excessive accumulation of glycogen in the hepatocytes.Cases: Two cases with poorly controlled diabetes and glycogenic hepatopathy are presented. First patient was a 28 year old female with 20 year history...

ea0034p103 | Clinical practice/governance and case reports | SFEBES2014

The use of s.c. denosumab for cases of hypercalcaemia refractory to i.v. bisphosphonate therapy

Khan Muhammad , Perkins Karen , Joseph Franklin

Despite i.v. bisphosphonates, including pamidronate and zoledronate, representing the established agents used to reduce calcium levels, a proportion of patients with hypercalcemia either fail to respond to such treatments or relapse following their use.We present a case of hypercalcaemia refractory to conventional treatments that was treated with the use of the human MAB denosumab.A 70-year-old male presented to the emergency depar...

ea0031p68 | Clinical practice/governance and case reports | SFEBES2013

Novel use of subcutaneous octreotide via an insulin pump for postural orthostatic tachycardia syndrome

Khan Muhammad , Perkins Karen , Joseph Franklin

Postural orthostatic tachycardia syndrome (PoTS) reflects a disturbance of autonomic function leading to a myriad of clinical features. Subcutaneous octreotide injections and intramuscular long acting preparations of octreotide have been used in the treatment of PoTS. However, inconvenience of frequent injections, side effects and theoretical overexposure, as well as cost of the intramuscular preparation, makes them far from ideal.We present a case of un...

ea0050cc08 | Featured Clinical Cases | SFEBES2017

Pseudohypervitaminosis D due to assay interference

Khan Muhammad Ilyas , Ali Shah Syed Saad , Chikthimmah Vineeth

Assay interference with various laboratory measurements has been reported in the presence of paraproteins. We report a case of a 57 year old woman, who was referred to endocrine clinic after being found to have elevated total vitamin D levels of 369 and 336 nmol/l (normal 50–100 nmol/l). She was not known to be on any Vitamin D supplements that could account for such high levels. Around the time of referral, she was also diagnosed with IgM paraproteinaemia. Therefore, pos...

ea0050cc08 | Featured Clinical Cases | SFEBES2017

Pseudohypervitaminosis D due to assay interference

Khan Muhammad Ilyas , Ali Shah Syed Saad , Chikthimmah Vineeth

Assay interference with various laboratory measurements has been reported in the presence of paraproteins. We report a case of a 57 year old woman, who was referred to endocrine clinic after being found to have elevated total vitamin D levels of 369 and 336 nmol/l (normal 50–100 nmol/l). She was not known to be on any Vitamin D supplements that could account for such high levels. Around the time of referral, she was also diagnosed with IgM paraproteinaemia. Therefore, pos...

ea0034p313 | Pituitary | SFEBES2014

Optochiasmal cavernoma presenting with secondary hypogonadism: a case report

Ahluwalia Rupa , Khan Muhammad , Das Kumar , Sinha Ajay , Vora Jiten

Background: We report a case of a 35-year-old male presenting with pituitary dysfunction secondary to an optochiasmal cavernoma.The gentleman was initially referred with gynaecomastia and biochemical tests consistent with secondary hypogonadism. On further questioning he also reported extremely lethargy, difficulties with weight loss and poor libido. Examination was consistent with features of hypogonadism with reduced body hair, bilateral gynaecomastia ...

ea0034p339 | Reproduction | SFEBES2014

Hyperandrogenism secondary to ovarian hyperthecosis masked by concurrent use of an aromatase inhibitor: a case report

Khan Muhammad , Ahluwalia Rupa , Shore Susannah , Waghorn Alison , Vora Jiten

Backgound: We report a case of a 63-year-old postmenopausal female diagnosed with ovarian hyperthecosis masked by concurrent use of an aromatase inhibitor.Following diagnosis of breast cancer in 2009, requiring mastectomy with adjunctive chemotherapy, she was commenced on anastrozole. Later she noted gradual onset of frontal balding and hirsutism. Biochemistry revealed elevated serum levels of testosterone 13.2 nmol/l (range: <1.9 nmol/l) and androst...

ea0081ep878 | Reproductive and Developmental Endocrinology | ECE2022

Characteristics of male idiopathic hypogonadotropic hypogonadism (IHH) patients

Saleem Muhammad , Ram Nanik , Khan Sajjad Ali , Mustansir Mehdi Khan Muhammad

Background: Idiopathic Hypogonadotropic Hypogonadism (IHH) is a condition caused by deficiency or insensitivity to gonadotropin-releasing hormone where the pathology behind the mechanism is unknown and no secondary causes of hypogonadotropic hypogonadism are present. The condition not only effect sexual characteristic but can affect the physical and psychosocial development of a patient therefore making its prompt diagnoses and treatment necessary. The purpose of this study wa...

ea0038p11 | Bone | SFEBES2015

The effect of oestradiol circadian rhythm on the bone mineral density of adult males

Wijetilleka Sajini , Khan Muhammad , Mon Aung , Joseph Frank , Fraser William , Vora Jiten

Background: Circulating levels of total oestradiol (E2) decrease with age in adult males; the effect of altered E2 circadian rhythm is uncertain. We hypothesised that age-related changes in the circadian rhythm contribute to decreased BMD in older males and investigated this.Methods: Nineteen subjects were studied: six young-healthy (YH) males (mean age (years) 27.3±4.6) with normal BMD, eight older-healthy (OH) males (mean age...